Cardiologist: GLP-1 Drugs Benefits Beyond Weight Loss for Heart, Liver

Cardiologist Dmitry Yaranov states GLP-1 drugs like Ozempic, Wegovy, and Mounjaro offer benefits far beyond weight loss. They enhance cardiovascular health, combat fatty liver disease, and improve blood sugar control in diabetes patients. These medications could redefine treatment for heart, liver, and metabolic diseases.

Cardiologist on the Expanding Role of GLP-1 Medications

Dmitry Yaranov, a cardiologist specializing in advanced heart failure, heart transplants, and mechanical circulatory support, shares insights on GLP-1 medications such as Ozempic, Wegovy, and Mounjaro.

These drugs provide benefits that extend well beyond weight loss, positioning them as potential game-changers in managing chronic conditions.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Key Benefits for Heart, Liver, and Metabolic Health

Improved cardiovascular health: GLP-1 drugs support better heart function and reduce related risks.
Reduction in fatty liver disease: They help address non-alcoholic fatty liver issues common in metabolic disorders.
Enhanced blood sugar control: Ideal for diabetes management, promoting stable glucose levels.

Yaranov emphasizes that GLP-1 medications represent the future of treating heart, liver, and metabolic diseases through multifaceted mechanisms.

Source Information

Originally published by Hindustan Times.Read the original article →

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read

Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read

Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read

Same topic: GLP-1

All GLP-1 articles →

Metabolic Health

New Obesity Pills in the UAE: Navigating Insurance Coverage for Wegovy and Foundayo

As new weight-loss medications enter the UAE market, patients are questioning insurance coverage. We break down the realities of policy, medical necessity, and the future of metabolic health.

2 min read

Healthcare Policy

Medicare Expands GLP-1 Coverage: What the 2027 Policy Shift Means for Seniors

The federal government has extended its commitment to fund GLP-1 obesity medications through 2027, shifting away from private insurer mandates to protect seniors from premium hikes.

2 min read

Medical Research

Tirzepatide vs. Semaglutide: A Comprehensive Guide to Cost and Health Outcomes

A new lifetime economic analysis suggests tirzepatide may offer superior long-term value and clinical outcomes compared to semaglutide for obesity management.

2 min read

More in GLP-1 Medications

Health & Wellness

Beyond the Dose: Why Some GLP-1s Fall Short & What It Means

A groundbreaking Stanford study reveals a genetic reason why approximately 10% of individuals don't respond as expected to GLP-1 receptor agonists, impacting treatments for diabetes and weight loss.

7 min read

Medical News

Beyond Ozempic: New Muscle-Burning Pill Reshaping Diabetes Care

A new experimental medication from Karolinska Institute targets muscle metabolism rather than appetite, offering a potential alternative to Ozempic and Wegovy with fewer side effects.

6 min read